Suiqing Zhou

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing Medical University · ORCID：0009-0002-3795-8039

发表论文 16 篇 · 总被引 480 次 · h-index 8

代表论文

• Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma (2023 · Journal of Hepatology · 被引 152)
• PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells (2022 · Nature Communications · 被引 122)
• Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners (2023 · Cell Metabolism · 被引 53)
• CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma (2024 · Cancer Letters · 被引 36)
• eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma (2025 · Journal of Hepatology · 被引 30)
• Etomidate elicits anti-tumor capacity by disrupting the JAK2/STAT3 signaling pathway in hepatocellular carcinoma (2022 · Cancer Letters · 被引 26)